California cannabis sales hold steady at $1.01B in Q2 2026
Second-quarter retail sales flatten year-over-year after multi-year decline, signaling potential market floor.

Classic vintage sign of The Empress Jewelry Shop, highlighting urban aesthetics and nostalgic charm.
Sales Plateau Ends Three-Year Contraction
California's $1.013 billion in Q2 retail sales matched the prior-year quarter, breaking a streak of consecutive quarterly declines that eroded operator margins and forced consolidation across the state's licensed supply chain. The flat performance follows Q1 2026 sales of $987 million, down 4.2% year-over-year. It's the first quarter since Q3 2023 where the state's legal market didn't contract compared to the same period a year earlier.
Operators had braced for further erosion. Multi-state operators with California exposure — including Curaleaf, Cresco Labs, and Glass House Brands — had flagged pricing pressure and illicit competition in recent earnings calls as headwinds specific to the state.
For context on California's regulatory and market evolution, see the CannIntel topic hub on the California cannabis market.
Pricing Dynamics and Consumer Behavior Shifts
The revenue plateau doesn't reflect volume growth — unit sales remain under pressure from illicit market share estimated at 60-65% of total California consumption. Instead, operators report that average selling prices have firmed modestly after bottoming in Q4 2025, when wholesale flower hit a statewide average of $680 per pound, down from $1,200 in mid-2023.
Retail prices for premium eighths in Los Angeles and San Francisco have held in the $35-$45 range through Q2, compared to $28-$38 a year ago, according to market data from Headset. But the price recovery is narrow. It applies primarily to top-shelf indoor flower and live resin concentrates, while mid-tier and bulk products continue to compress.
The math suggests consumers are trading up within the legal channel rather than expanding the legal customer base — a sign that California's tax burden and enforcement gaps remain structural drags on market capture.
Tax Revenue Implications for State Budget
Flat sales translate to flat excise tax collections, which generated approximately $101 million in Q2 at California's 10% retail rate. The state's cannabis tax revenue has declined from a peak of $1.29 billion in fiscal year 2022-23 to an estimated $1.1 billion in FY 2025-26, forcing budget adjustments in programs funded by the Cannabis Tax Fund.
Governor Gavin Newsom's revised budget proposal in May 2026 had anticipated a 3% year-over-year decline in cannabis receipts, a forecast that Q2 data now appears to validate. Still, the stabilization offers Sacramento a planning baseline after years of volatile downward revisions.
Operator Consolidation and Market Structure
The revenue floor coincides with accelerated M&A activity as undercapitalized operators exit or merge. In Q2 alone, California saw 47 retail license surrenders and 12 cultivation licenses non-renewed, according to Department of Cannabis Control filings. Glass House Brands acquired two Southern California dispensary chains in April and June. Cookies expanded to 18 California storefronts through a sale-leaseback structure.
Consolidation is concentrating market share among vertically integrated operators who can absorb the state's tax and compliance costs. Smaller single-license retailers face a tougher reality. Particularly in rural counties with limited foot traffic, they face unsustainable unit economics even as top-line sales stabilize.
What Operators Are Watching Next
The key variable for H2 2026 is whether federal rescheduling to Schedule III materializes and whether California adjusts its tax structure in response. If the DEA finalizes its proposed rule moving cannabis to Schedule III, California operators would gain access to standard business deductions under Section 280E, improving EBITDA margins by an estimated 8-12 percentage points for profitable operators.
State lawmakers have floated proposals to lower the 10% excise tax to 8% or eliminate the cultivation tax entirely, but no bill has advanced past committee. Without tax reform or meaningful illicit market enforcement, the Q2 plateau may represent a new equilibrium rather than the start of recovery.
The next quarterly data release is expected in mid-November. Operators will be parsing whether the stabilization holds through the critical Q4 holiday season, when California historically captures 28-30% of annual sales.
Frequently asked questions
What caused California cannabis sales to stabilize in Q2 2026?
Sales stabilized due to modest wholesale and retail price recovery after hitting multi-year lows in Q4 2025, combined with ongoing consolidation that has reduced oversupply. The plateau does not reflect volume growth or expanded legal market share.
How much tax revenue did California collect from cannabis in Q2 2026?
California collected approximately $101 million in cannabis excise tax revenue in Q2 2026, based on the 10% retail tax rate applied to $1.013 billion in sales. This matches prior-year collections and validates state budget forecasts.
What is the current size of California's illicit cannabis market?
Industry analysts estimate the illicit market captures 60-65% of total California cannabis consumption. This share has remained stable despite enforcement efforts, driven by the state's tax burden and limited regulatory resources.
How would federal Schedule III rescheduling affect California operators?
Schedule III rescheduling would allow California operators to deduct ordinary business expenses under federal tax law, eliminating the Section 280E burden. This would improve EBITDA margins by an estimated 8-12 percentage points for profitable operators.
Which California cannabis operators are consolidating market share?
Vertically integrated operators including Glass House Brands, Cookies, and Curaleaf are acquiring distressed retailers and expanding store counts. Glass House added two Southern California chains in Q2, while Cookies reached 18 California locations through sale-leaseback deals.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business

Cresco Labs Acquires Nine Pennsylvania Dispensaries for $50M
Multi-state operator expands Pennsylvania footprint through all-cash deal for medical cannabis retail locations.

Cresco Labs Acquires 9 Pennsylvania Dispensaries for $50 Million
The Chicago-based MSO expands its Pennsylvania footprint through a nine-location deal in the state's medical-only market.

Study Links Cannabis Legalization to Rising Workplace Absenteeism
New research connects state-level cannabis laws to measurable increases in employee sick days and unscheduled absences.
More from the newsroom

San Diego Board Approves Cannabis Retail Expansion in Unincorporated Areas
The Board of Supervisors voted to allow more cannabis storefronts in county-controlled communities outside city limits.

Ontario Police Seize 4,100 Cannabis Plants from Greenhouse Licensed for 1,750
Niagara Regional Police raided a Wainfleet facility holding 134% more plants than its Health Canada cultivation license permitted.

Humboldt Sheriff Tells DEA Illicit Market Thrives Despite Legalization
County law enforcement reports black-market cannabis operations still dominate Northern California's Emerald Triangle despite eight years of legal sales.